| 07.09. | THETA GOLD MINES LIMITED (ASX : TGM) Issue of New Call Options to 2Invest AG |  |
| 11.08. | 2invest AG Reports Earnings Results for the Half Year Ended June 30, 2022 | |
| 13.05. | THETA GOLD MINES LIMITED (ASX : TGM) Option to Extend Secure Bond Maturity Date | |
| 20.04. | 2invest AG Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 23.03. | Heqet Therapeutics S.R.L. announced that it has received £6.6 million in funding from C.. | |
| 16.03. | Kither Biotech s.r.l. announced that it has received €18.5 million in funding from.. | |
| 25.02. | 2INVEST : Preliminary annual results as of 31 December 2021 | |
| 2021 | 2INVEST : Change of forecast for the financial year 2021 | |
| 2021 | Revocation of the admission to the Prime Standard | |
| 2021 | Leucid Bio Ltd announced that it has received ?11.5 million in funding from Epidarex Ca.. | |
| 2021 | 2Invest Ag Reports Earnings Results for the Half Year Ended June 30, 2021 | |
| 2021 | 2INVEST : Preliminary half-year results as of 30.06.2021 | |
| 2021 | 2INVEST : Report of the Supervisory Board of 2invest AG for the financial year from 1 Janu.. | |
| 2021 | 4BASEBIO : Quarterly statement as at 31 March 2021 published | |
| 2021 | 4BASEBIO : Application for change from Prime Standard to General Standard | |
| 2021 | 4BASEBIO : Implementation of the reverse stock split of 4basebio AG | |
| 2021 | 4BASEBIO : KROMI takeover offer will not be pursued further | |
| 2021 | 4BASEBIO : Preliminary annual result as of 31.12.2020 | |
| 2021 | 4Basebio Ag Provides Earnings Guidance for the Full Year Ended December 31, 2020 | |
| 2021 | 4BASEBIO : Further processing of the spin-off | |
| 2021 | 4BASEBIO : reports on results of the Extraordinary General Meeting 2021 | |
| 2021 | 4BASEBIO : Decision to make a public takeover offer to the shareholders of KROMI Logistik .. | |
| 2021 | 4basebio AG cancelled the acquisition of KROMI Logistik AG. | |
| 2020 | 4basebio AG Announces Board Changes | |
| 2020 | 4BASEBIO : Update regarding the status of the settlement of the spin-off | |
| 2020 | 4BASEBIO : reports on registration of spin-off and explains further settlement process | |
| 2020 | 4basebio AG completed the spin-off of Genomics and DNA manufacturing business. | |
| 2020 | 4BASEBIO : reports change in Supervisory Board and new appointment to the Executive Manage.. | |
| 2020 | 4basebio AG Announces Board Changes | |
| 2020 | 4Basebio Ag Reports Earnings Results for the Nine Months Ended September 30, 2020 | |
| 2020 | 4BASEBIO : reports first nine months of 2020 financial results | |
| 2020 | EXPEDEON : 4basebio reports on results of Extraordinary General Meeting 2020 | |
| 2020 | EXPEDEON : 4basebio announces share capital reduction by way of reverse stock split | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : 4basebio AG signs term sheet for investment in nanoparticle-based gene therapy .. | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : 4basebio comments on the takeover bid of Sparta AG | |
| 2020 | 4BASEBIO AG : 4basebio comments on the takeover bid of Sparta AG | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Mitteilung über Eigengeschäfte von Führungskräften gem. Art. 19 MAR | |
| 2020 | EXPEDEON : 4basebio AG announces process for spin-off and separate stock market listing fo.. | |
| 2020 | 4BASEBIO : announces process for spin-off and separate stock market listing for its DNA bu.. | |
| 2020 | The Board of Directors of 4basebio AG announced the spin-off of unknown majority stake .. | |
| 2020 | TRANSCRIPT : 4basebio AG, H1 2020 Earnings Call, Aug 13, 2020 | |
| 2020 | 4basebio AG Reaffirms Earnings Guidance for the Full Year of 2020 | |
| 2020 | 4BASEBIO AG : 4basebio AG reports first six months of 2020 financial results | |
| 2020 | 4Basebio Ag Reports Earnings Results for the Second Quarter Ended June 30, 2020 | |
| 2020 | 4BASEBIO AG : 4basebio informs about takeover bid by Sparta AG | |
| 2020 | SPARTA AG (DB : SPT6) made an offer to acquire remaining 95.8% stake in 4basebio AG for &#.. | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | EXPEDEON : Managers' transactions announcement according to article 19 MAR | |
| 2020 | 4BASEBIO AG : 4basebio reports on results of Annual General Meeting 2020 | |
| 2020 | 4BASEBIO AG : Notification and public disclosure of transactions by persons | |
| 2020 | 4BASEBIO AG : Simple and rapid SARS-CoV-2 diagnostic test project with 4basebio's contribu.. | |
| 2020 | 4BASEBIO AG : 4basebio AG reports first quarter 2020 financial results | |
| 2020 | 4basebio AG Reaffirms Earning Guidance for the Fiscal Year 2020 | |
| 2020 | Tranche Update on 4basebio AG's Equity Buyback Plan announced on December 19, 2019. | |
| 2020 | TRANSCRIPT : 4basebio AG, 2019 Earnings Call, Apr 24, 2020 | |
| 2020 | 4BASEBIO AG : 4basebio AG Reports positive Financial Results for Fiscal Year 2019 - Financ.. | |
| 2020 | 4Basebio Ag Reports Earnings Results for the Full Year Ended December 31, 2019 | |
| 2020 | Tranche Update on 4basebio AG's Equity Buyback Plan announced on December 19, 2019. | |
| 2020 | 4BASEBIO AG : 4basebio provides Phi29 DNA polymerase variants and expertise to develop imp.. | |
| 2020 | 4basebio AG Provides Phi29 DNA polymerase variants and expertise to develop improved de.. | |
| 2020 | 4BASEBIO AG : 4basebio AG resolves on capital reduction by way of redemption of approx. 5... | |
| 2020 | 4BASEBIO AG : Notification and public disclosure of transactions by persons | |
| 2020 | EXPEDEON : 4basebio AG announces allotment ratio and final number of shares for the share .. | |
| 2020 | 4BASEBIO AG : 4basebio AG announces allotment ratio and final number of shares for the sha.. | |
| 2020 | 4basebio AG's Equity Buyback announced on December 19, 2019, has closed with 5,584,558 .. | |
| 2020 | EXPEDEON : Notification of the allotment ratio for the share buy back | |
| 2020 | EXPEDEON : 4basebio AG announces results of the public share buyback offer and final purch.. | |
| 2020 | 4BASEBIO AG : 4basebio AG announces results of the public share buyback offerand final pur.. | |
| 2020 | AD HOC : 4basebio AG decides to increase the public share buyback offer volume from 2,056,.. | |
| 2020 | EXPEDEON : 4basebio AG decides to increase the public share buyback offer volume from 2,05.. | |
| 2020 | 4BASEBIO AG : 4basebio AG decides to increase the public share buyback offer volume from 2.. | |
| 2020 | 4BASEBIO AG : 4basebio AG decides to increase the public share buyback offer volume from 2.. | |
| 2020 | 4BASEBIO AG : 4basebio AG decides to buy back 2 million treasury shares | |
| 2020 | 4BASEBIO AG : 4basebio AG decides to buy back 2 million treasury shares for further use in.. | |
| 2020 | 4BASEBIO AG : Expedeon AG completes change of name to 4basebio AG and of ticker symbol to .. | |
| 2020 | Expedeon AG has Changed its Name to 4basebio AG | |
| 2020 | ABCAM : announces successful acquisition of Expedeon's Proteomics and Immunology business,.. | |
| 2020 | EXPEDEON : Abcam announces successful acquisition of Expedeon's Proteomics and Immunology .. | |
| 2020 | EXPEDEON : and Abcam plc close EUR 120 million transaction | |
| 2020 | EXPEDEON AG : Expedeon AG and Abcam plc close EUR 120 million transaction | |
| 2020 | Abcam plc completed the acquisition of TGR Biosciences Pty Ltd, Innova Biosciences Ltd... | |
| 2019 | EXPEDEON AG : Notification and public disclosure of transactions by persons | |
| 2019 | EXPEDEON AG : Notification and public disclosure of transactions by persons | |
| 2019 | EXPEDEON : shareholders approve sale of proteomics & immunotherapy business and name chang.. | |
| 2019 | EXPEDEON AG : Expedeon shareholders approve sale of proteomics & immunotherapy business an.. | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht